他莫昔芬体外促进HepG2细胞脂肪变性观察 |
| |
引用本文: | 赵斐,谢萍,姜佳丽,张令强,安威,展玉涛.他莫昔芬体外促进HepG2细胞脂肪变性观察[J].实用肝脏病杂志,2014(1):30-33. |
| |
作者姓名: | 赵斐 谢萍 姜佳丽 张令强 安威 展玉涛 |
| |
作者单位: | [1]首都医科大学附属北京同仁医院消化科,北京市100730 [2]军事医学科学院放射与辐射医学研究所 ,北京市100730 [3]首都医科大学基础医学院细胞生物学系,北京市100730 |
| |
基金项目: | 肝脏保护与再生调节北京市重点实验室课题(2013年资助) |
| |
摘 要: | 目的:研究他莫昔芬(TAM)对体外培养的HepG2细胞脂肪变性以及脂类代谢调控关键因子表达的影响。方法应用油酸(50μmol/L)处理HepG2细胞,诱导细胞脂肪变性体外模型,同时给予不同浓度的TAM (5~20μmol/L)干预72 h;采用油红O染色和甘油三酯含量测定检测HepG2细胞内脂质聚集情况;应用蛋白印迹法检测固醇调节元件结合蛋白-1c(SREBP-1c)、脂肪酸合成酶(FAS)、硬脂酰辅酶A去饱和酶(SCD)、肉酯软脂酰基转移酶(CPT1)和微粒体甘油三酯转移蛋白(MTP)的表达;采用细胞活性检测试剂盒测定细胞活性。结果在干预72 h后,模型组细胞内甘油三酯含量为(16.53±0.17) mg/100 mg蛋白质,在5μmol/L TAM处理细胞内甘油三酯含量为(17.77±0.05) mg/100mg蛋白质,与模型组无显著性差异,但在10μmol/L和20μmol/L TAM处理组较模型组分别增加了31%(21.57±0.16) mg/100 mg蛋白质]和44%(23.82±0.44) mg/100 mg蛋白质],(P<0.05);TAM上调细胞内SREBP-1c、FAS、SCD和MTP蛋白表达,但并不改变CPT1蛋白表达;TAM在5~20μmol/L范围内不影响HepG2细胞活性。结论 TAM可促进油酸诱导的HepG2细胞脂肪变性,其主要机制可能是通过上调SREBP-1c及其下游基因,如FAS和SCD的表达而增加了脂肪酸的合成。
|
关 键 词: | HepG2细胞 他莫昔芬 脂肪变 甘油三酯 脂肪酸合成 |
Tamoxifen promotes lipid accumulation in HepG2 cells in vitro |
| |
Institution: | Zhao Fei,Xie Ping,Jiang Jiali,et al.( Department of Gastroenterology, Tongren Hospital, Capital Medical University ,Beijing 100730, China) |
| |
Abstract: | Objective To investigate the effect of tamoxifen(TAM) on steatosis in HepG2 cells in vitro and on the expression of key regulators involved in lipid metabolism in the cells. Methods A cell model of steatosis was induced in HepG2 cells in vitro with oleic acid (OA) at 50 μmol/L;HepG2 cells were then subjected to dif-ferent concentrations of TAM (5 to 20 μmol/L) at the presence of OA for 72 h;Intracellular lipid accumulation was assessed by oil red O staining and measurement of triglyceride;The expression of sterol regulatory element-binding protein-1c(SREBP-1c),fatty acid synthase(FAS),steroyl-CoA desaturase(SCD),carnitine palmitoyltrans-ferase 1(CPT1)and mitochondrial trifunctional protein(MTP)was determined by Western blot;Cell viability was de-tected by cell counting Kit-8 assay. Results After incubation for 72 h,the intracellular triglyceride in control group was (16.53±0.17) mg/100 mg protein,similar to that of cells treated with 5μmol/L TAM,however,the intra-cellular triglyceride was increased by 31%(21.57±0.16) mg/100 mg protein] and 44%(23.82±0.44) mg/100 mg protein] in cells treated with 10 μmol/L and 20 μmol/L of TAM,respectively(P〈±0.05);TAM treatment(5 to 10 μmol/L) significantly increased the expression of SREBP-1c,FAS,SCD and MTP without affecting the expression of carni-tine palmitoyltransferase 1 (CPT1) in HepG2 cells;TAM did not affect HepG2 viability. Conclusions TAM pro-motes OA-induced cell steatosis,probably by up-regulation of SREBP-1c,FAS and SCD,thus increases fatty acid synthesis in the cells. |
| |
Keywords: | HepG 2 cells Tamoxifen Steatosis Triglyceride Fatty acid synthesis |
本文献已被 维普 等数据库收录! |
|